86 related articles for article (PubMed ID: 9758898)
1. Eosinophil degranulation in the presence of lung fibroblasts.
Takafuji S; Shoji S; Ito K; Yamamoto K; Nakagawa T
Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():52-4. PubMed ID: 9758898
[TBL] [Abstract][Full Text] [Related]
2. Effects of human lung fibroblasts on eosinophil degranulation.
Takafuji S; Miyakuni Y; Nakagawa T; Shoji S; Murata S; Yamamoto K; Ito K
Allergy; 2000 Dec; 55(12):1170-8. PubMed ID: 11117275
[TBL] [Abstract][Full Text] [Related]
3. Eosinophil degranulation in the presence of bronchial epithelial cells. Effect of cytokines and role of adhesion.
Takafuji S; Ohtoshi T; Takizawa H; Tadokoro K; Ito K
J Immunol; 1996 May; 156(10):3980-5. PubMed ID: 8621939
[TBL] [Abstract][Full Text] [Related]
4. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a.
Takafuji S; Tadokoro K; Ito K
Allergy; 1996 Aug; 51(8):563-8. PubMed ID: 8874660
[TBL] [Abstract][Full Text] [Related]
5. Degranulation from human eosinophils stimulated with C3a and C5a.
Takafuji S; Tadokoro K; Ito K; Dahinden CA
Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):27-9. PubMed ID: 8156000
[TBL] [Abstract][Full Text] [Related]
6. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
Egesten A; Malm J
Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
[TBL] [Abstract][Full Text] [Related]
7. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
Carlson M; Peterson C; Venge P
Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the release of eosinophil cationic protein by eosinophil adhesion.
Xu X; Håkansson L
Clin Exp Allergy; 2000 Jun; 30(6):794-806. PubMed ID: 10848898
[TBL] [Abstract][Full Text] [Related]
9. Activation of eosinophils with cytokines produced by lung mast cells.
Okayama Y; Kobayashi H; Ashman LK; Holgate ST; Church MK; Mori M
Int Arch Allergy Immunol; 1997 Oct; 114 Suppl 1():75-7. PubMed ID: 9363932
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil granulocyte interaction with serum-opsonized particles: binding and degranulation are enhanced by tumor necrosis factor alpha.
Egesten A; Blom M; Calafat J; Janssen H; Knol EF
Int Arch Allergy Immunol; 1998 Feb; 115(2):121-8. PubMed ID: 9482700
[TBL] [Abstract][Full Text] [Related]
11. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.
Simon HU; Weber M; Becker E; Zilberman Y; Blaser K; Levi-Schaffer F
J Immunol; 2000 Oct; 165(7):4069-75. PubMed ID: 11034418
[TBL] [Abstract][Full Text] [Related]
12. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
Takafuji S; Tadokoro K; Ito K; Nakagawa T
Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
[TBL] [Abstract][Full Text] [Related]
13. Effects of physiologic soluble agonists on leukotriene C4 production and degranulation by human eosinophils.
Takafuji S; Tadokoro K; Ito K; Dahinden CA
Int Arch Allergy Immunol; 1995; 108 Suppl 1():36-8. PubMed ID: 7549519
[TBL] [Abstract][Full Text] [Related]
14. A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation.
Agrawal DK; Takami M; Ono S
Inflammation; 1997 Feb; 21(1):1-8. PubMed ID: 9179617
[TBL] [Abstract][Full Text] [Related]
15. The effect of eosinophils on collagen gel contraction and implications for tissue remodelling.
Zagai U; Sköld CM; Trulson A; Venge P; Lundahl J
Clin Exp Immunol; 2004 Mar; 135(3):427-33. PubMed ID: 15008974
[TBL] [Abstract][Full Text] [Related]
16. Eosinophil-fibroblast interactions. Granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6-type cytokine production.
Rochester CL; Ackerman SJ; Zheng T; Elias JA
J Immunol; 1996 Jun; 156(11):4449-56. PubMed ID: 8666820
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism.
Olszewska-Pazdrak B; Pazdrak K; Ogra PL; Garofalo RP
J Immunol; 1998 May; 160(10):4889-95. PubMed ID: 9590236
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations.
Zeck-Kapp G; Kroegel C; Riede UN; Kapp A
Allergy; 1995 Jan; 50(1):34-47. PubMed ID: 7741187
[TBL] [Abstract][Full Text] [Related]
19. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils.
Benson M; Strannegård IL; Strannegård O; Wennergren G
J Allergy Clin Immunol; 2000 Aug; 106(2):307-12. PubMed ID: 10932075
[TBL] [Abstract][Full Text] [Related]
20. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival.
Meng Q; Ying S; Corrigan CJ; Wakelin M; Assoufi B; Moqbel R; Kay AB
Allergy; 1997 Nov; 52(11):1095-101. PubMed ID: 9404561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
